CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoPOLUZZI, ELISABETTA
Pubblicazioni
Risultati 1 - 20 di 146 (tempo di esecuzione: 0.001 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | |
|---|---|---|---|---|---|---|
| 1 | A 3 year survey on the use of antibacterial agents in five Italian hospitals. | Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N. | 2008 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1.01 Articolo in rivista | |
| 2 | A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. | Silvani M.C.; Poluzzi E.; Motola D.; Quaranta P.; Nanetti A.; Ambretti S.; Fiacchi P.; Puggioli C....; Vaccheri A.; Montanaro N. | 2009 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 4.02 Riassunto (Abstract) | |
| 3 | Aderenza alla terapia antidepressiva in Emilia-Romagna | Poluzzi E; Sangiorgi E; Piccinni C; Clo M | 2012 | ISTISAN CONGRESSI | 4.02 Riassunto (Abstract) | |
| 4 | Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage | Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Pont...i F.; Montanaro N. | 2007 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1.01 Articolo in rivista | |
| 5 | Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. | Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggia...ni G; Montanaro N. | 2006 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4.02 Riassunto (Abstract) | |
| 6 | Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy | Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N. | 2008 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1.01 Articolo in rivista | |
| 7 | Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies | Roberto, G; Raschi, E.; Piccinni, C.; Conti, V.; Vignatelli, L.; D'Alessandro, R.; De Ponti, F.; ...Poluzzi, E. | 2015 | CEPHALALGIA | 1.01 Articolo in rivista | |
| 8 | Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems | Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, France...sca; Mazzanti, Gabriela; De Ponti, Fabrizio | 2018 | DRUG SAFETY | 1.01 Articolo in rivista | |
| 9 | Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems | Raschi, E.; Parisotto, M.; Forcesi, E.; La Placa, M.; Marchesini, G.; De Ponti, F.; Poluzzi, E. | 2017 | NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | 1.01 Articolo in rivista | |
| 10 | Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study | Mostacci, Barbara; Poluzzi, Elisabetta; D'Alessandro, Roberto; Cocchi, Guido; Tinuper, Paolo | 2018 | JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY | 1.04 Replica / breve intervento (e simili) | |
| 11 | An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. | Silvani MC; Bersaglia L; Poluzzi E; Motola D; Bottoni A; Strahinja P; Vargiu A; Vaccheri A; Monta...naro N. | 2007 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 4.02 Riassunto (Abstract) | |
| 12 | Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region | Sacripanti C; Piccinni C; Puccini A; Poluzzi E; Montanaro N | 2011 | 4.02 Riassunto (Abstract) | ||
| 13 | Antibacterial macrolides: a drug class with a complex pharmacological profile | ABU-GHARBIEH E.; VASINA V.; POLUZZI E.; DE PONTI F. | 2004 | PHARMACOLOGICAL RESEARCH | 1.01 Articolo in rivista | |
| 14 | Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. | M. C. Silvani; L. Bersaglia; E. Poluzzi; D. Motola; A. Nanetti; S. Ambretti; A. Bottoni; A. Vacch...eri; N. Montanaro. | 2008 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4.02 Riassunto (Abstract) | |
| 15 | Antibiotic use in Italian hospitals 2002-2004. | Silvani MC; Poluzzi E; Motola D; Strahinja P; Vargiu A; Bersaglia L; Vaccheri A; Montanaro N. | 2006 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4.02 Riassunto (Abstract) | |
| 16 | Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project | Mor, Anil; Frøslev, Trine; Thomsen, Reimar Wernich; Oteri, Alessandro; Rijnbeek, Peter; Schink, T...ania; Garbe, Edeltraut; Pecchioli, Serena; Innocenti, Francesco; Bezemer, Irene; Poluzzi, Elisabetta; Sturkenboom, Miriam C.; Trifirò, Gianluca; Søgaard, Mette | 2015 | INFECTION | 1.01 Articolo in rivista | |
| 17 | Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. | E. Poluzzi; E. Raschi; D. Motola; U. Moretti; F. De Ponti | 2009 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 1.01 Articolo in rivista | |
| 18 | Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System | E. Poluzzi; E. Raschi; D. Motola; U. Moretti; F. De Ponti | 2010 | DRUG SAFETY | 1.01 Articolo in rivista | |
| 19 | Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. | Poluzzi E;Raschi E;Koci A;Moretti U;Spina E;Behr ER;Sturkenboom M;De Ponti F | 2013 | DRUG SAFETY | 1.01 Articolo in rivista | |
| 20 | Apparato Gastroenterico | E. Raschi; E. Poluzzi | 2011 | Elsevier | 5.02 Contributo in volume (Traduzione) |
Dettaglio
POLUZZI, ELISABETTA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Copyright © 2020